SICHUAN KELUN PHARMACEUTICAL RESEARCH INSTITUTE CO. LTD.
发明人:
Zhengxing SU,Likai YANG,Dong ZHAO,Jing ZHOU,Fengying SHAN,Lichun WANG,Jingyi WANG
申请号：
US16582295
公开号：
US20200038362A1
申请日:
2019.09.25
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a docetaxel albumin nanoparticle pharmaceutical composition, a preparation method therefor, and a use thereof for manufacturing drugs for treating cancer. The pharmaceutical composition comprises docetaxel, albumin and amino acid(s), wherein the weight ratio between albumin and docetaxel is no more than 50, preferably is 20:1 to 1:1, and the weight ratio between amino acid(s) and docetaxel is not less than 0.5, preferably is 1:1 to 20:1.
